A review of the evidence for efficacy of complementary and alternative medicines in MS

International MS Journal

Volumn 13, Issue 1, 2006, Pages 4-12

  Huntley, A ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Complementary and alternative medicine; Efficacy; Multiple sclerosis; Safety

Indexed keywords

CANNABIS; DOCOSAHEXAENOIC ACID; DRONABINOL; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; PRIMROSE OIL;

ACUPUNCTURE; ALTERNATIVE MEDICINE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; EXPANDED DISABILITY STATUS SCALE; FELDENKRAIS METHOD; GROUP THERAPY; HOMEOPATHY; HUMAN; IMAGERY; INTERVIEW; MAGNETOTHERAPY; MASSAGE; MULTIPLE SCLEROSIS; MUSIC THERAPY; OUTCOMES RESEARCH; PALLIATIVE THERAPY; PATIENT ATTITUDE; QUESTIONNAIRE; REFLEXOLOGY; REVIEW; SYMPTOM; YOGA;

EID: 31544436344     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. US Government Printing Office. Alternative Medicine. Expanding medical horizons: a report to the National Institutes of Health of alternative medical systems and practices in the United States. 1994. Washington.
2. Compston DAS. Demyelinating disorders of the CNS. In: Wetherall DJ, Leadingham JGG, Warell DA (eds). Oxford Textbook of Medicine. Section 24.9. Oxford: Oxford University Press, 1990; pp3992-3996.
3. Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC. Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil 2003; 17: 181-191.
4. Stuifbergen AK, Harrison TC. Complementary and alternative therapy use in persons with multiple sclerosis. Rehabil Nurs 2003; 28: 141-147, 158.
5. Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. The use of complementary and alternative therapies by people with multiple sclerosis. Chronic Dis Can 2003; 24: 75-79.
6. Sastre-Garriga J, Munteis E, Rio J, Pericot I, Tintore M, Montalban X. Unconventional therapy in multiple sclerosis. Mult Scler 2003; 9: 320-322.
7. Somerset M Campbell R, Sharp DJ, Peters TJ. What do people with MS want and expect from health-care services? Health Expect 2001; 4: 29-37.
8. Pucci E, Cartechini E, Taus C, Giuliani G. Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients. Eur J Neurol 2004; 11: 263-267.
9. Agranoff BW, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet 1974; ii: 1061-1066.
10. Alter M, Yamoor M, Harshe M. Multiple sclerosis and nutrition. Arch Neurol 1974; 31: 267-272.
11. O'Shea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr 2004; 79 (Suppl 6): 1199S-1206S.
12. Millar JH, Zilkha KJ, Langman MJ, Wright HP, Smith AD, Belin J et al. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J 1973; 1: 765-768.
13. Bates D, Fawcett PR, Shaw DA, Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J 1978; 2: 1390-1391.
14. Paty DW. Double-blind trial of linoleic acid in multiple sclerosis. Arch Neurol 1983; 40: 693-694.
15. Dworkin RH, Bates D, Millar JH, Paty DW. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology 1984; 34: 1441-1445.
16. Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, Shaw DA et al. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989; 52: 18-22.
17. Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 2000; 102: 143-149.
18. Hernandez-Reif M, Field T, Field T, Theakston H. Multiple sclerosis patients benefit from massage therapy. J Bodywork Movement Ther 1998; 2: 168-174.
19. Johnson SK, Frederick J, Kaufman M, Mountjoy B. A controlled investigation of bodywork in multiple sclerosis. J Altern Complement Med 1999; 5: 237-243.
20. Siev-Ner I, Gamus D, Lerner-Geva L, Achiron A. Reflexology treatment relieves symptoms of multiple sclerosis: a randomized controlled study. Mult Scler 2003; 9: 356-361.
21. Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004; 62: 2058-2064.
22. Poison MJ, Barker AT, Freeston IL. Stimulation of nerve trunks with time-varying magnetic fields. Med Biol Eng Comput 1982; 20: 243-244.
23. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; i: 1106-1107.
24. Nielsen JF, Sinkjaer T, Jakobsen J. Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study. Mult Scler 1996; 2: 227-232.
25. Richards TL, Lappin MS, Acosta-Urquidi J, Kraft GH, Heide AC, Lawrie FW et al. Double-blind study of pulsing magnetic field effects on multiple sclerosis. J Altern Complement Med 1997; 3: 21-29.
26. Lappin MS, Lawrie FW, Richards TL, Kramer ED. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial. Altern Ther Health Med 2003; 9: 38-48.
27. Gibson RG, Gibson SL. Neural therapy in the treatment of multiple sclerosis. J Altern Complement Med 1999; 5: 543-552.
28. Crawford JD, Mclvor GP. Group psychotherapy: benefits in multiple sclerosis. Arch Phys Med Rehabil 1985; 66: 810-813.
29. Maguire BL. The effects of imagery on attitudes and moods in multiple sclerosis patients. Altern Ther Health Med 1996; 2: 75-79.
30. Nordoff P and Robbin C. Creative Music Therapy. New York: John Day, 1977.
31. Schmid W, Aldridge D. Active music therapy in the treatment of multiple sclerosis patients: a matched control study. J Music Ther 2004; 41: 225-240.
32. Mills N, Allen J. Mindfulness of movement as a coping strategy in multiple sclerosis. A pilot study. Gen Hosp Psychiatry 2000; 22: 425-431.
33. Killestein J, Hoogervorst EL, Reif M, Kalkers NF, Van Loenen AC, Staats PG et al. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 2002; 58: 1404-1407.
34. Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003; 362: 1517-1526.
35. Fox P, Bain PG, Glickman S, Carroll C, Zajicek J. The effect of cannabis on tremor in patients with multiple sclerosis. Neurology 2004; 62: 1105-1109.
36. Vaney C, Heinzel-Gutenbrunner M, Jobin P, Tschopp F, Gattlen B, Hagen U et al. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler 2004; 10: 417-424.
37. Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 2004; 10: 434-441.
38. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-872.
39. Suchard JR, Suchard MA, Steinfeldt JL. Physician knowledge of herbal toxicities and adverse herb-drug interactions. Eur J Emerg Med 2004; 11: 193-197.
40. Giveon SM, Liberman N, Klang S, Kahan E. A survey of primary care physicians' perceptions of their patients' use of complementary medicine. Complement Ther Med 2003; 11: 254-260.